Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis

Critical Care Medicine

Volumn 34, Issue 9, 2006, Pages 2432-2438

  Maybauer, Marc O ^a,b   Maybauer, Dirk M ^a,b   Fraser, John F ^c   Traber, Lillian D ^a   Westphal, Martin ^a,d   Enkhbaatar, Perenlei ^a   Cox, Robert A ^a   Huda, Ruksana ^a   Hawkins, Hal K ^a   Morita, Naoki ^a   Murakami, Kazunori ^a   Mizutani, Akio ^e   Herndon, David N ^a   Traber, Daniel L ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e OITA UNIVERSITY   (Japan)

Author keywords

3 nitrotyrosine; Acute lung injury; Acute respiratory distress syndrome; Airway; Nitric oxide; Septic shock; Sheep

Indexed keywords

3 NITROTYROSINE; DROTRECOGIN; RINGER LACTATE SOLUTION;

ACUTE LUNG INJURY; AERATION; AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD CLOTTING TIME; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG INFUSION; FEMALE; FIBRINOLYSIS; INTENSIVE CARE UNIT; LUNG ARTERY PRESSURE; LUNG BURN; LUNG EDEMA; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RELIABILITY; RESUSCITATION; SEPSIS; SHEEP; THROMBOCYTE COUNT; TRACHEOTOMY;

AIRWAY OBSTRUCTION; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; FEMALE; FIBRINOLYTIC AGENTS; INFUSIONS, INTRAVENOUS; LUNG; NITRATES; NITRITES; ORGAN SIZE; PROSPECTIVE STUDIES; PROTEIN C; PULMONARY EDEMA; RANDOM ALLOCATION; RECOMBINANT PROTEINS; RESPIRATORY FUNCTION TESTS; SEPSIS; SHEEP; SMOKE INHALATION INJURY; TYROSINE;

EID: 33747604392     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000230384.61350.FA     Document Type: Article

References (29)

1. Rue LW III, Cioffi WG, Mason AD Jr, et al: The risk of pneumonia in thermally injured patients requiring ventilatory support. J Burn Care Rehabil 1995; 16:262-268
2. Shirani KZ, Pruitt BA Jr, Mason AD Jr: The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987; 205:82-87
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
4. Liaw PC: Endogenous protein C activation in patients with severe sepsis. Crit Care Med 2004; 32:S214-S218
5. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
6. Ely EW, Laterre PF, Angus DC, et al: Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003; 31:12-19
7. Vincent JL, Angus DC, Artigas A, et al: Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003; 31:834-840
8. Dhainaut JF, Yan SB, Claessens YE: Protein C/activated protein C pathway: Overview of clinical trial results in severe sepsis. Crit Care Med 2004; 32:S194-S201
9. Murakami K, Bjertnaes LJ, Schmalstieg FC, et al: A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med 2002; 30:2083-2090
10. Maybauer DM, Salsbury JR, Westphal M, et al: The ATP-sensitive potassium-channel inhibitor glibenclamide improves outcome in an ovine model of hemorrhagic shock. Shock 2004; 22:387-391
11. Maybauer MO, Kikuchi Y, Westphal M, et al: Effects of manganese superoxide dismutase nebulization on pulmonary function in an ovine model of acute lung injury. Shock 2005; 23:138-143
12. Bernard GR, Ely EW, Wright TJ, et al: Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 2001; 29:2051-2059
13. Maybauer MO, Maybauer DM, Traber LD, et al: Gentamicin improves hemodynamics in ovine septic shock following smoke inhalation injury. Shock 2005; 24:226-231
14. Cox RA, Burke AS, Soejima K, et al: Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 2003; 29:295-302
15. Murakami K, McGuire R, Cox RA, et al: Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 2003; 31:577-583
16. Murakami K, Okajima K, Uchiba M, et al: Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996; 87:642-647
17. Gunther A, Mosavi P, Heinemann S, et al: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:454-462
18. Seeger W, Grube C, Gunther A: Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity. Am J Respir Cell Mol Biol 1993; 9:239-247
19. Idell S, Peterson BT, Gonzalez KK, et al: Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury. Am Rev Respir Dis 1988; 138:1282-1294
20. Vervloet MG, Thijs LG, Hack CE: Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998; 24:33-44
21. Taoka Y, Okajima K, Uchiba M, et al: Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 1998; 18:1393-1398
22. Yamaguchi Y, Hisama N, Okajima K, et al: Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver. Hepatology 1997; 25:1136-1140
23. Gajewski J, Povar ML: Blood coagulation values of sheep. Am J Vet Res 1971; 32:405-409
24. Liaw PC, Esmon CT, Kahnamoui K, et al: Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004; 104:3958-3964
25. Wong SS, Sun NN, Hyde JD, et al: Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1 beta in rats. Lung 2005; 182:319-330
26. Murakami K, Okajima K, Uchiba M, et al: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272:L197-L202
27. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6:79-88
28. Sturn DH, Kaneider NC, Feistritzer C, et al: Expression and function of the endothelial protein C receptor in human neutrophils. Blood 2003; 102:1499-1505
29. Nick JA, Coldren CD, Geraci MW, et al: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004; 104:3878-3885